NEW YORK – LGC Clinical Diagnostics on Tuesday announced a partnership with AccuGenomics to jointly develop quality control materials for next-generation sequencing tests. Financial terms of the codevelopment agreement were not disclosed. The collaboration will make use of LGC’s expertise in quality control and AccuGenomics’ NGS monitoring technologies. The goal is to develop accurate and reliable molecular diagnostics and quality…
For more information:• Message us for a confidential conversation• Follow us on LinkedIn